• K+ Channel Blockade Worsens Renal Blood Flow in Septic Rats

  2026-05-19

  This study investigates how blocking ATP-sensitive and calcium-activated potassium channels affects renal blood flow in septic rats treated with norepinephrine or phenylephrine. The findings reveal that certain channel blockers, when combined with vasoactive agents, can exacerbate reductions in kidney perfusion, offering mechanistic insights valuable for vascular biology and sepsis research.

• Resiniferatoxin (RTX): Strategic Guidance for Translational

  2026-05-19

  This article delivers actionable insights for translational researchers working with Resiniferatoxin (RTX), focusing on its mechanistic impact on TRPV1-positive sensory neurons, immune modulation, and protocol optimization. It integrates recent evidence from preclinical and immunological studies, contextualizes RTX within the competitive landscape, and provides a forward-looking outlook grounded in cited findings. Strategic guidance is offered to accelerate translational advances while highlighting APExBIO’s RTX as a gold-standard research tool.

• Improving In Vitro Drug Response Evaluation in Cancer Resear

  2026-05-18

  Schwartz’s dissertation critically re-examines how in vitro assays measure drug responses in cancer, differentiating between proliferation arrest and cell death. Her work proposes more precise viability metrics and highlights the need for workflow-aware evaluation to improve translational relevance in preclinical oncology.

• Protease Inhibitor Cocktail EDTA-Free: Precision for Sensiti

  2026-05-18

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO empowers researchers to safeguard protein integrity in workflows demanding preservation of phosphorylation and enzyme activity. Its unique EDTA-free formulation enables robust protease inhibition during extraction and analysis, overcoming common pitfalls in advanced immunochemical and signaling studies.

• Etoposide (VP-16): Optimizing DNA Damage Assays in Cancer Re

  2026-05-17

  Etoposide (VP-16) from APExBIO is a gold standard for inducing DNA double-strand breaks and apoptosis in cancer cell models, offering robust, reproducible results for DNA damage assays and chemotherapy research. This guide highlights stepwise protocols, troubleshooting strategies, and the latest high-throughput permeability model insights to maximize experimental reliability and translational value.

• Magneto-Piezoelectric Scaffolds Activate JAK2-STAT3 in Bone

  2026-05-16

  This study presents a multifunctional scaffold enhanced with magneto-piezoelectric nanoparticles, enabling simultaneous disruption of bacterial biofilms and activation of oxidative phosphorylation in Icam1+ macrophages. By stimulating the JAK2-STAT3 pathway, the approach promotes bone regeneration in infectious defect models, pointing to new therapeutic strategies for complex orthopedic infections.

• Synergy of Copper and Hexetidine Against Oral Streptococci

  2026-05-15

  This article examines the seminal study by Grytten et al. on the synergistic antibacterial effects of copper ions and Hexetidine (NSC-17764) against Streptococcus sobrinus and Streptococcus sanguis. The findings clarify how combining these agents can significantly lower the minimum inhibitory concentration required for oral streptococcal inhibition, with implications for biofilm assays and anti-plaque research.

• Latrunculin A: Precision Disruption of the Actin Cytoskeleto

  2026-05-15

  This article explores how Latrunculin A, a reversible inhibitor of actin assembly, is revolutionizing cytoskeletal research at the interface of cell biology and virology. Drawing on recent proteomic and functional studies, we provide mechanistic insights, protocol parameters, and strategic guidance for translational researchers leveraging APExBIO's Latrunculin A to interrogate actin–myosin II networks in models of cell morphology, motility, and viral pathogenesis.

• Gut-Brain Cholinergic Signaling in B. fragilis Antiseizure E

  2026-05-14

  Jia et al. reveal that Bacteroides fragilis suppresses seizures via gut-brain cholinergic signaling, specifically by activating colonic ChAT+ cells and enhancing vagal acetylcholine transmission. Their work provides mechanistic and translational evidence for microbiota-targeted therapies in pediatric refractory epilepsy.

• Live-Dead Cell Staining Kit: Precision Cell Viability Assays

  2026-05-14

  Empower your cell-based research with the APExBIO Live-Dead Cell Staining Kit, leveraging robust Calcein-AM Propidium Iodide staining for clear, quantitative viability assessment. Discover applied workflows, troubleshooting strategies, and comparative insights that set this kit apart for flow cytometry and fluorescence microscopy.

• Hydrocortisone in Inflammation Model Research: Protocols & I

  2026-05-13

  Hydrocortisone stands as the benchmark glucocorticoid hormone for dissecting anti-inflammatory pathways, barrier function, and stress response in translational research. This article delivers actionable workflows, precise protocol parameters, and troubleshooting strategies for maximizing reproducibility with APExBIO’s hydrocortisone in advanced inflammation and neurodegeneration models.

• First-Line Strategies for SCLC: Topotecan and Etoposide Insi

  2026-05-13

  The referenced review examines topotecan-based regimens as first-line therapies for small cell lung cancer (SCLC), focusing on their efficacy, toxicity, and comparison with established cisplatin/etoposide combinations. The paper highlights the manageable toxicity profile of topotecan and the continued role of etoposide as a key topoisomerase II inhibitor in SCLC treatment. These findings guide researchers seeking to design preclinical and translational studies targeting DNA damage and apoptotic pathways in cancer cells.

• Neuroinflammation and Piezo2 in Trigeminal Neuralgia: Mechan

  2026-05-12

  Liao et al. reveal a neuroinflammatory cascade in trigeminal neuralgia (TN) involving the CGRP/SP-Piezo2 axis and Ca2+ signaling. Their findings clarify how mechanical allodynia arises from molecular crosstalk, offering new mechanistic understanding and experimental targets for pain research.

• Canagliflozin Remodels Mitochondria in Diabetic Kidney Cells

  2026-05-12

  This study demonstrates that Canagliflozin, beyond its role as an SGLT2 inhibitor, induces structural and functional improvements in the mitochondria of proximal tubular cells in hypertensive–diabetic mice. These findings provide mechanistic insight into kidney-protective effects relevant for diabetes and renal research.

• Metoprolol Tartrate: Precision β1 Blockade for Translational

  2026-05-11

  This thought-leadership article bridges mechanistic insight with strategic guidance for translational researchers exploring β1-adrenergic blockade in cardiovascular and regenerative medicine. Drawing on recent evidence, we clarify how Metoprolol Tartrate’s receptor selectivity shapes experimental outcomes, especially in hematopoietic regeneration and heart failure models. By integrating protocol recommendations, comparative analysis, and actionable outlooks, this piece positions APExBIO’s Metoprolol Tartrate as a gold-standard tool, while advancing beyond standard product pages and linking to foundational research.

482 records 13/33 page Previous Next First page 上5页 1112131415 下5页 Last page